A_DT
mechanism_NN
for_IN
the_DT
antiinflammatory_JJ
effects_NNS
of_IN
corticosteroids_NNS
:_:
the_DT
glucocorticoid_NN
receptor_NN
regulates_VBZ
leukocyte_NN
adhesion_NN
to_TO
endothelial_JJ
cells_NNS
and_CC
expression_NN
of_IN
endothelial-leukocyte_JJ
adhesion_NN
molecule_NN
1_CD
and_CC
intercellular_JJ
adhesion_NN
molecule_NN
1_CD
._.

Corticosteroids_NNS
are_VBP
the_DT
preeminent_JJ
antiinflammatory_JJ
agents_NNS
although_IN
the_DT
molecular_JJ
mechanisms_NNS
that_WDT
impart_VBP
their_PRP$
efficacy_NN
have_VBP
not_RB
been_VBN
defined_VBN
._.

The_DT
endothelium_NN
plays_VBZ
a_DT
critical_JJ
role_NN
in_IN
inflammation_NN
by_IN
directing_VBG
circulating_VBG
leukocytes_NNS
into_IN
extravascular_JJ
tissues_NNS
by_IN
expressing_VBG
adhesive_JJ
molecules_NNS
for_IN
leukocytes_NNS
-LCB-_-LRB-
e.g._FW
,_,
endothelial-leukocyte_JJ
adhesion_NN
molecule_NN
1_CD
-LRB-_-LRB-
ELAM-1_NN
-RRB-_-RRB-
and_CC
intercellular_JJ
adhesion_NN
molecule_NN
1_CD
-LRB-_-LRB-
ICAM-1_NN
-RRB-_-RRB-
-RCB-_-RRB-
._.

We_PRP
therefore_RB
determined_VBD
whether_IN
corticosteroids_NNS
suppress_VBP
inflammation_NN
by_IN
inhibiting_VBG
endothelial_JJ
expression_NN
of_IN
adhesion_NN
molecules_NNS
for_IN
neutrophils_NNS
-LRB-_-LRB-
polymorphonuclear_JJ
leukocytes_NNS
-RRB-_-RRB-
._.

Preincubation_NN
of_IN
endothelial_JJ
cells_NNS
with_IN
endotoxin_NN
-LCB-_-LRB-
lipopolysaccharide_NN
-LRB-_-LRB-
LPS_NN
-RRB-_-RRB-
,_,
1_CD
microgram\/ml_NN
-RCB-_-RRB-
led_VBD
to_TO
a_DT
4-fold_JJ
increase_NN
in_IN
subsequent_JJ
adherence_NN
of_IN
polymorphonuclear_JJ
leukocytes_NNS
-LRB-_-LRB-
P_NN
&lt;_JJR
0.0001_CD
,_,
n_NN
=_JJ
10_CD
-RRB-_-RRB-
to_TO
endothelial_JJ
cells_NNS
,_,
an_DT
increase_NN
that_WDT
was_VBD
markedly_RB
attenuated_VBN
when_WRB
endothelial_JJ
cells_NNS
were_VBD
treated_VBN
with_IN
dexamethasone_NN
-LRB-_-LRB-
IC50_NN
&lt;_JJR
1_CD
nM_NN
,_,
P_NN
&lt;_JJR
0.0001_CD
,_,
n_NN
=_JJ
6_CD
or_CC
7_CD
-RRB-_-RRB-
during_IN
preincubation_NN
with_IN
LPS_NN
._.

Moreover_RB
,_,
the_DT
steroid_NN
receptor_NN
agonist_NN
cortisol_NN
-LRB-_-LRB-
10_CD
microM_NN
-RRB-_-RRB-
,_,
but_CC
not_RB
its_PRP$
inactive_JJ
metabolite_NN
tetrahydrocortisol_NN
-LRB-_-LRB-
10_CD
microM_NN
-RRB-_-RRB-
,_,
diminished_VBD
LPS-induced_JJ
endothelial_JJ
cell_NN
adhesiveness_NN
._.

Further_JJ
evidence_NN
that_IN
the_DT
action_NN
of_IN
dexamethasone_NN
was_VBD
mediated_VBN
through_IN
ligation_NN
of_IN
corticosteroid_NN
receptors_NNS
-LCB-_-LRB-
human_JJ
glucocorticoid_NN
receptors_NNS
-LRB-_-LRB-
hGRs_NNS
-RRB-_-RRB-
-RCB-_-RRB-
was_VBD
provided_VBN
by_IN
experiments_NNS
utilizing_VBG
the_DT
steroid_NN
antagonist_NN
RU-486_NN
._.

RU-486_NN
-LRB-_-LRB-
10_CD
microM_NN
-RRB-_-RRB-
,_,
which_WDT
prevents_VBZ
translocation_NN
of_IN
ligated_VBN
hGR_NN
to_TO
the_DT
nucleus_NN
by_IN
inhibiting_VBG
dissociation_NN
of_IN
hGR_NN
from_IN
heat_NN
shock_NN
protein_NN
90_CD
,_,
completely_RB
aborted_VBD
the_DT
effect_NN
of_IN
dexamethasone_NN
on_IN
adhesiveness_NN
of_IN
endothelial_JJ
cells_NNS
-LRB-_-LRB-
P_NN
&lt;_JJR
0.0005_CD
,_,
n_NN
=_JJ
3_CD
-RRB-_-RRB-
._.

Treatment_NN
of_IN
endothelial_JJ
cells_NNS
with_IN
LPS_NN
-LRB-_-LRB-
1_CD
microgram\/ml_NN
-RRB-_-RRB-
stimulated_VBD
transcription_NN
of_IN
ELAM-1_NN
,_,
as_IN
shown_VBN
by_IN
Northern_NN
blot_NN
analysis_NN
,_,
and_CC
expression_NN
of_IN
membrane-associated_JJ
ELAM-1_NN
and_CC
ICAM-1_NN
,_,
as_IN
shown_VBN
by_IN
quantitative_JJ
immunofluorescence_NN
-LRB-_-LRB-
both_DT
P_NN
&lt;_JJR
0.001_CD
,_,
n_NN
=_JJ
9_CD
-RRB-_-RRB-
._.

Dexamethasone_NN
markedly_RB
inhibited_VBD
LPS-stimulated_JJ
accumulation_NN
of_IN
mRNA_NN
for_IN
ELAM-1_NN
and_CC
expression_NN
of_IN
ELAM-1_NN
and_CC
ICAM-1_NN
-LRB-_-LRB-
IC50_NN
&lt;_JJR
10_CD
nM_NN
,_,
both_DT
P_NN
&lt;_JJR
0.001_CD
,_,
n_NN
=_JJ
4-9_CD
-RRB-_-RRB-
;_:
inhibition_NN
of_IN
expression_NN
by_IN
dexamethasone_NN
was_VBD
reversed_VBN
by_IN
RU-486_NN
-LRB-_-LRB-
both_DT
P_NN
&lt;_JJR
0.005_CD
,_,
n_NN
=_JJ
4-6_CD
-RRB-_-RRB-
._.

As_IN
in_IN
the_DT
adhesion_NN
studies_NNS
,_,
cortisol_NN
but_CC
not_RB
tetrahydrocortisol_NN
inhibited_VBD
expression_NN
of_IN
ELAM-1_NN
and_CC
ICAM-1_NN
-LRB-_-LRB-
both_DT
P_NN
&lt;_JJR
0.005_CD
,_,
n_NN
=_JJ
3_CD
or_CC
4_CD
-RRB-_-RRB-
._.

In_IN
contrast_NN
,_,
sodium_NN
salicylate_NN
-LRB-_-LRB-
1_CD
mM_NN
-RRB-_-RRB-
inhibited_VBD
neither_CC
adhesion_NN
nor_CC
expression_NN
of_IN
these_DT
adhesion_NN
molecules_NNS
._.

These_DT
studies_NNS
suggest_VBP
that_IN
antagonism_NN
by_IN
dexamethasone_NN
of_IN
endotoxin-induced_JJ
inflammation_NN
is_VBZ
a_DT
specific_JJ
instance_NN
of_IN
the_DT
general_JJ
biological_JJ
principle_NN
that_IN
the_DT
glucocorticoid_NN
receptor_NN
is_VBZ
a_DT
hormone-dependent_JJ
regulator_NN
of_IN
transcription_NN
._.

